Does telemedicine follow-up reduce surgical site infection in pregnant women? A pilot feasibility study
Published
May 5, 2025
Paper ID
PAP-000267
Status
Published
DOI
10.65712/tmj.test000525
Advance Services
Abstract
Background: Earlier studies of telemedicine follow-up were small or single-centre. Methods: Missing data were handled with multiple imputation. Results: The adjusted odds ratio was 0.77 (95% CI 0.22 to 0.61). surgical site infection occurred in 12% of the intervention group versus 22% of controls. Conclusion: Implementation will depend on staffing, cost and local protocols.
References
1. Rahman L, Novak F, et al. SGLT2 inhibitors and surgical site infection. N Engl J Med. 2015;316(2):564-1732.
2. Haddad I, Zhang L, et al. Prone positioning and time to diagnosis. Lancet. 2025;356(1):735-1011.
3. Okafor E, Andersen S, et al. Machine-learning triage and 30-day readmission. BMC Med. 2016;168(4):34-1399.
4. Ibrahim E, Rossi K, et al. Early enteral nutrition and ventilator-free days. Crit Care Med. 2021;15(2):321-1027.
5. Osei O, Nasser V, et al. Early mobilisation and glycaemic control. N Engl J Med. 2023;159(4):803-1135.
6. Volkov N, Yilmaz S, et al. Frailty screening and chronic pain scores. Pediatrics. 2018;307(9):240-1230.
7. Nakamura X, Yilmaz I, et al. Low-dose aspirin and glycaemic control. N Engl J Med. 2025;12(12):459-1698.
Introduction
Earlier studies of telemedicine follow-up were small or single-centre. surgical site infection remains a leading cause of avoidable harm among pregnant women. Guidelines make only a weak recommendation on telemedicine follow-up.
surgical site infection remains a leading cause of avoidable harm among pregnant women. The cost of surgical site infection to health systems is substantial.
Practice around telemedicine follow-up varies widely between centres. surgical site infection remains a leading cause of avoidable harm among pregnant women. Guidelines make only a weak recommendation on telemedicine follow-up.
Materials and Methods
Missing data were handled with multiple imputation. The primary outcome was surgical site infection, assessed blind to allocation. Analyses were adjusted for age, sex and baseline severity.
The primary outcome was surgical site infection, assessed blind to allocation. Analyses were adjusted for age, sex and baseline severity.
We conducted a pilot feasibility study across 7 centres between 2019 and 2024. The primary outcome was surgical site infection, assessed blind to allocation. Eligible participants were pregnant women.
Results
Effects were consistent across prespecified subgroups. surgical site infection occurred in 10% of the intervention group versus 15% of controls.
| Group | n | Events |
|---|---|---|
| Age < 65 | 495 | 41 |
| Intervention | 438 | 73 |
| Age ≥ 65 | 797 | 24 |
| Centre A | 31 | 23 |
| Centre B | 742 | 56 |
| Control | 178 | 98 |
Values are n (%) unless stated otherwise.

Shown for pregnant women; error bars are 95% confidence intervals.
The adjusted odds ratio was 0.67 (95% CI 0.20 to 0.84). The adjusted odds ratio was 0.80 (95% CI 0.34 to 0.83). surgical site infection occurred in 6% of the intervention group versus 38% of controls.
Discussion
Strengths include the sample size and blinded outcome assessment. Residual confounding cannot be excluded.
Residual confounding cannot be excluded. Implementation will depend on staffing, cost and local protocols.
These findings suggest that telemedicine follow-up is associated with better surgical site infection in pregnant women. Future work should test telemedicine follow-up in a pragmatic multicentre trial. Implementation will depend on staffing, cost and local protocols.
Future work should test telemedicine follow-up in a pragmatic multicentre trial. Residual confounding cannot be excluded. Implementation will depend on staffing, cost and local protocols.
These findings suggest that telemedicine follow-up is associated with better surgical site infection in pregnant women. Residual confounding cannot be excluded.
Conclusions
Telemedicine follow-up merits wider use for pregnant women to improve surgical site infection.
Appendices
The statistical analysis plan is in the online supplement.